US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

53.16

-1.5500-2.83%

Post-market: 53.00-0.1600-0.30%18:19 EDT

Volume:995.59K

Turnover:53.36M

Market Cap:7.66B

PE:-9.44

High:55.52

Open:55.21

Low:52.89

Close:54.71

52wk High:71.22

52wk Low:27.66

Shares:144.00M

Float Shares:116.97M

Volume Ratio:0.57

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.6300

EPS(LYR):-5.6333

ROE:-25.59%

ROA:-17.72%

PB:2.85

PE(LYR):-9.44

Loading ...

Overview Company News Filings

Vaxcyte: Expects to Report Topline Safety, Tolerability and Immunogenicity Data From Both Opus-2 and Opus-3 Phase 3 Studies in First Half of 2027

THOMSON REUTERS

Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine

How Immunization Schedule Changes And Analyst Optimism Could Reframe Vaxcyte’s (PCVX) Vaccine Platform Narrative

Simply Wall St.

Vaxcyte Inc : Needham Raises Target Price to $110 From $90

THOMSON REUTERS

Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal Reports Disposal of Common Shares

Trade Alert: Senior Vice President of Finance Of Vaxcyte Elvia Cowan Has Sold Stock

Simply Wall St.

This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%. -- Barrons.com

Vaxcyte Raises Executive Severance Multipliers in Amended Agreements

Vaxcyte (PCVX): Reassessing Valuation After OPUS Phase 3 Trial Start for Next-Generation Pneumococcal Vaccine

Simply Wall St.

BRIEF-Vaxcyte Says Topline Results From OPUS Trial Expected In Q4 2026

Vaxcyte Begins Phase 3 Trial of VAX-31 Pneumococcal Vaccine in Adults

Vaxcyte Doses First Participants in the Opus Phase 3, Noninferiority Trial Evaluating Vax-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

THOMSON REUTERS

Vaxcyte Inc - Topline Results From Opus Trial Expected in Q4 2026

THOMSON REUTERS

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements

Tiger Newspress

Top Premarket Decliners

MT Newswires Live

S&P 500 Futures Fall In Premarket Trading; Vaxcyte, Cipher Mining Lag

U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology

Vaxcyte Inc : Leerink Partners Raises Target Price to $77 From $60

THOMSON REUTERS

Is Vaxcyte’s (PCVX) Aggressive R&D Spend Still Justified Amid Widening Losses?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PCVX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":53.16,"timestamp":1774641600000,"preClose":54.71,"halted":0,"volume":995594,"hourTrading":{"tag":"盘后","latestPrice":53,"preClose":53.16,"latestTime":"18:19 EDT","volume":44773,"amount":2378786.19,"timestamp":1774649989003,"change":-0.16,"changeRate":-0.00301,"amplitude":0.012415},"delay":0,"changeRate":-0.028331200877353396,"floatShares":116968635,"shares":144000000,"eps":-5.63,"marketStatus":"Market Closed","change":-1.55,"latestTime":"03-27 16:00:00 EDT","open":55.21,"high":55.52,"low":52.89,"amount":53364976.363942,"amplitude":0.048072,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.63,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":54.71,"preHourTrading":{"tag":"盘前","latestPrice":54.2,"preClose":54.71,"latestTime":"09:12 EDT","volume":7124,"amount":387538.76096,"timestamp":1774617136423,"change":-0.51,"changeRate":-0.009322,"amplitude":0.161762},"postHourTrading":{"tag":"盘后","latestPrice":53,"preClose":53.16,"latestTime":"18:19 EDT","volume":44773,"amount":2378786.19,"timestamp":1774649989003,"change":-0.16,"changeRate":-0.00301,"amplitude":0.012415},"volumeRatio":0.567665,"impliedVol":0.533,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","floatShares":116968635,"roa":"-17.72%","roe":"-25.59%","lyrEps":-5.633263,"volumeRatio":0.567665,"shares":144000000,"dividePrice":0,"high":55.52,"amplitude":0.048072,"preClose":54.71,"low":52.89,"week52Low":27.66,"pbRate":"2.85","week52High":71.22,"institutionHeld":0,"latestPrice":53.16,"eps":-5.63,"divideRate":0,"volume":995594,"delay":0,"ttmEps":-5.63,"open":55.21,"prevYearClose":46.14,"prevWeekClose":54.72,"prevMonthClose":61.74,"prevQuarterClose":46.14,"fiveDayClose":54.72,"twentyDayClose":61.74,"sixtyDayClose":45.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-24","symbol":"PCVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-1.8},{"market":"US","date":"2025-11-04","symbol":"PCVX","fiscalQuarterEnding":"2025/09","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.56},{"market":"US","date":"2025-08-06","symbol":"PCVX","fiscalQuarterEnding":"2025/06","expectedEps":-1.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.22},{"market":"US","date":"2025-05-07","symbol":"PCVX","fiscalQuarterEnding":"2025/03","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-1.04},{"market":"US","date":"2025-02-25","symbol":"PCVX","fiscalQuarterEnding":"2024/12","expectedEps":-1.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.5,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1769832000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCVX","date":"2026-03-27","current":-9.442274,"percent":0.808354,"low":-29.340195,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"high":-7.035423,"avg":-15.327221,"sd":5.142908,"marketCap":7873882950},"quantilePoints":[{"date":"2021-04-01","current":-12.041287,"twenty":-33.584786,"median":-25.323184,"eighty":-15.836525,"marketCap":1074287463},{"date":"2021-04-09","current":-11.632815,"twenty":-33.392638,"median":-24.94854,"eighty":-15.78625,"marketCap":1037844840},{"date":"2021-04-16","current":-10.487676,"twenty":-33.311269,"median":-22.709441,"eighty":-15.55327,"marketCap":935679026},{"date":"2021-04-23","current":-10.919386,"twenty":-33.218824,"median":-21.912403,"eighty":-15.299444,"marketCap":974194902},{"date":"2021-04-30","current":-10.689141,"twenty":-33.190027,"median":-21.287036,"eighty":-15.131453,"marketCap":953653102},{"date":"2021-05-07","current":-10.153821,"twenty":-33.084719,"median":-21.011138,"eighty":-15.018642,"marketCap":905893415},{"date":"2021-05-14","current":-11.86778,"twenty":-32.847359,"median":-20.348984,"eighty":-14.778304,"marketCap":988526765},{"date":"2021-05-21","current":-12.058997,"twenty":-32.68146,"median":-19.922875,"eighty":-14.531835,"marketCap":1004454171},{"date":"2021-05-28","current":-12.996577,"twenty":-32.555937,"median":-19.594864,"eighty":-14.291498,"marketCap":1082549841},{"date":"2021-06-04","current":-13.502376,"twenty":-32.459267,"median":-19.294442,"eighty":-13.543087,"marketCap":1124680399},{"date":"2021-06-11","current":-13.576395,"twenty":-32.326271,"median":-18.856071,"eighty":-13.573928,"marketCap":1130845847},{"date":"2021-06-18","current":-13.249476,"twenty":-32.218741,"median":-18.276686,"eighty":-13.543087,"marketCap":1103615120},{"date":"2021-06-25","current":-14.803884,"twenty":-32.08439,"median":-17.737153,"eighty":-13.491436,"marketCap":1233089520},{"date":"2021-07-02","current":-14.057522,"twenty":-31.944846,"median":-17.553221,"eighty":-13.501662,"marketCap":1170921256},{"date":"2021-07-09","current":-13.823127,"twenty":-31.815686,"median":-17.265061,"eighty":-13.436992,"marketCap":1151397339},{"date":"2021-07-16","current":-13.261813,"twenty":-31.674418,"median":-17.124047,"eighty":-13.30129,"marketCap":1104642695},{"date":"2021-07-23","current":-13.890978,"twenty":-31.579566,"median":-16.774577,"eighty":-13.380244,"marketCap":1157048999},{"date":"2021-07-30","current":-13.372842,"twenty":-31.455467,"median":-16.578383,"eighty":-13.387646,"marketCap":1113890866},{"date":"2021-08-06","current":-14.877903,"twenty":-31.365164,"median":-16.541596,"eighty":-13.436992,"marketCap":1239254967},{"date":"2021-08-13","current":-15.677143,"twenty":-31.259955,"median":-16.406713,"eighty":-13.486858,"marketCap":1358487192},{"date":"2021-08-20","current":-12.906692,"twenty":-31.167757,"median":-16.243279,"eighty":-13.436992,"marketCap":1118416463},{"date":"2021-08-27","current":-16.044529,"twenty":-31.042745,"median":-16.118553,"eighty":-13.486858,"marketCap":1390322658},{"date":"2021-09-03","current":-15.454303,"twenty":-30.799298,"median":-16.056575,"eighty":-13.501305,"marketCap":1339177155},{"date":"2021-09-10","current":-15.755439,"twenty":-30.533651,"median":-16.044529,"eighty":-13.509778,"marketCap":1365271800},{"date":"2021-09-17","current":-15.273621,"twenty":-30.399459,"median":-16.002108,"eighty":-13.545554,"marketCap":1323520369},{"date":"2021-09-24","current":-15.526575,"twenty":-30.296,"median":-15.971408,"eighty":-13.571461,"marketCap":1345439870},{"date":"2021-10-01","current":-15.797598,"twenty":-30.252261,"median":-15.938491,"eighty":-13.585031,"marketCap":1368925050},{"date":"2021-10-08","current":-14.544872,"twenty":-30.181073,"median":-15.881916,"eighty":-13.619573,"marketCap":1260371329},{"date":"2021-10-15","current":-14.701463,"twenty":-30.038168,"median":-15.83959,"eighty":-13.634377,"marketCap":1273940544},{"date":"2021-10-22","current":-13.6776,"twenty":-29.986874,"median":-15.836525,"eighty":-13.619573,"marketCap":1185218753},{"date":"2021-10-29","current":-14.093168,"twenty":-29.919091,"median":-15.822921,"eighty":-13.619573,"marketCap":1221229362},{"date":"2021-11-05","current":-15.243508,"twenty":-29.833872,"median":-15.797598,"eighty":-13.623951,"marketCap":1320910904},{"date":"2021-11-12","current":-15.134436,"twenty":-29.751073,"median":-15.774414,"eighty":-13.643873,"marketCap":1396166847},{"date":"2021-11-19","current":-12.994444,"twenty":-29.640151,"median":-15.762952,"eighty":-13.643873,"marketCap":1198750438},{"date":"2021-11-26","current":-11.363701,"twenty":-29.615934,"median":-15.755439,"eighty":-13.576395,"marketCap":1048312800},{"date":"2021-12-03","current":-11.054718,"twenty":-29.492837,"median":-15.662087,"eighty":-13.502376,"marketCap":1019808827},{"date":"2021-12-10","current":-12.439419,"twenty":-29.474665,"median":-15.610894,"eighty":-13.409852,"marketCap":1147548856},{"date":"2021-12-17","current":-12.679739,"twenty":-29.293034,"median":-15.552798,"eighty":-13.261813,"marketCap":1169718613},{"date":"2021-12-23","current":-13.82412,"twenty":-29.268816,"median":-15.502485,"eighty":-13.260579,"marketCap":1275288885},{"date":"2021-12-31","current":-13.612409,"twenty":-29.21926,"median":-15.450268,"eighty":-13.25441,"marketCap":1255758385},{"date":"2022-01-07","current":-13.612409,"twenty":-29.141782,"median":-15.412813,"eighty":-13.260579,"marketCap":1255758385},{"date":"2022-01-14","current":-11.644212,"twenty":-29.049569,"median":-15.345894,"eighty":-13.248242,"marketCap":1074190192},{"date":"2022-01-21","current":-10.46361,"twenty":-28.988298,"median":-15.279644,"eighty":-13.177704,"marketCap":965278474},{"date":"2022-01-28","current":-10.685347,"twenty":-28.867611,"median":-15.231462,"eighty":-13.055331,"marketCap":985733974},{"date":"2022-02-04","current":-10.739283,"twenty":-28.373067,"median":-15.186632,"eighty":-12.971556,"marketCap":990709637},{"date":"2022-02-11","current":-11.841978,"twenty":-27.884642,"median":-15.154572,"eighty":-12.789242,"marketCap":1092434287},{"date":"2022-02-18","current":-12.213538,"twenty":-27.569868,"median":-15.134436,"eighty":-12.66337,"marketCap":1126711071},{"date":"2022-02-25","current":-13.543962,"twenty":-27.447762,"median":-15.081457,"eighty":-12.60844,"marketCap":1249444073},{"date":"2022-03-04","current":-12.902121,"twenty":-27.407317,"median":-15.056803,"eighty":-12.655185,"marketCap":1291205520},{"date":"2022-03-11","current":-13.667358,"twenty":-27.190856,"median":-15.039487,"eighty":-12.697912,"marketCap":1367788141},{"date":"2022-03-18","current":-14.629531,"twenty":-26.912591,"median":-15.031927,"eighty":-12.729886,"marketCap":1464079526},{"date":"2022-03-25","current":-13.481675,"twenty":-26.806708,"median":-15.008832,"eighty":-12.75445,"marketCap":1349205593},{"date":"2022-04-01","current":-13.397274,"twenty":-26.56186,"median":-15.002599,"eighty":-12.786391,"marketCap":1340758981},{"date":"2022-04-08","current":-14.438221,"twenty":-26.252858,"median":-14.954417,"eighty":-12.801505,"marketCap":1444933870},{"date":"2022-04-14","current":-13.802399,"twenty":-26.169603,"median":-14.89419,"eighty":-12.812618,"marketCap":1381302722},{"date":"2022-04-22","current":-14.501863,"twenty":-26.054435,"median":-14.847747,"eighty":-12.834599,"marketCap":1451302975},{"date":"2022-04-29","current":-14.043604,"twenty":-25.893476,"median":-14.832093,"eighty":-12.903035,"marketCap":1405441800},{"date":"2022-05-06","current":-14.078409,"twenty":-25.749169,"median":-14.8193,"eighty":-12.912799,"marketCap":1408924928},{"date":"2022-05-13","current":-11.643665,"twenty":-25.696441,"median":-14.803884,"eighty":-12.798225,"marketCap":1372124372},{"date":"2022-05-20","current":-12.974793,"twenty":-25.63955,"median":-14.78197,"eighty":-12.727529,"marketCap":1528988570},{"date":"2022-05-27","current":-12.910464,"twenty":-25.529933,"median":-14.739625,"eighty":-12.727529,"marketCap":1521407772},{"date":"2022-06-03","current":-10.83707,"twenty":-25.468879,"median":-14.701463,"eighty":-12.638816,"marketCap":1277072833},{"date":"2022-06-10","current":-9.322849,"twenty":-25.378687,"median":-14.632372,"eighty":-12.529434,"marketCap":1098632519},{"date":"2022-06-17","current":-9.990888,"twenty":-25.323184,"median":-14.567395,"eighty":-12.411304,"marketCap":1177356187},{"date":"2022-06-24","current":-9.649446,"twenty":-25.295433,"median":-14.559871,"eighty":-12.356612,"marketCap":1137119646},{"date":"2022-07-01","current":-10.733153,"twenty":-25.027632,"median":-14.544872,"eighty":-12.280659,"marketCap":1264826929},{"date":"2022-07-08","current":-11.802015,"twenty":-24.945765,"median":-14.531772,"eighty":-12.208936,"marketCap":1390784797},{"date":"2022-07-15","current":-12.316652,"twenty":-23.952679,"median":-14.512216,"eighty":-12.136983,"marketCap":1451431178},{"date":"2022-07-22","current":-11.287377,"twenty":-22.944874,"median":-14.465518,"eighty":-12.125268,"marketCap":1330138416},{"date":"2022-07-29","current":-11.420985,"twenty":-22.588047,"median":-14.443856,"eighty":-12.103448,"marketCap":1345883150},{"date":"2022-08-05","current":-12.831289,"twenty":-22.429865,"median":-14.436004,"eighty":-12.081262,"marketCap":1512077560},{"date":"2022-08-12","current":-10.957188,"twenty":-21.819211,"median":-14.406349,"eighty":-11.987006,"marketCap":1563546932},{"date":"2022-08-19","current":-10.807545,"twenty":-21.413336,"median":-14.344728,"eighty":-11.893983,"marketCap":1542193484},{"date":"2022-08-26","current":-11.55576,"twenty":-21.328727,"median":-14.308806,"eighty":-11.856598,"marketCap":1648960725},{"date":"2022-09-02","current":-10.965502,"twenty":-21.257607,"median":-14.253853,"eighty":-11.805991,"marketCap":1564733234},{"date":"2022-09-09","current":-11.759441,"twenty":-21.228177,"median":-14.197019,"eighty":-11.782001,"marketCap":1678025140},{"date":"2022-09-16","current":-10.861583,"twenty":-21.051603,"median":-14.162382,"eighty":-11.765767,"marketCap":1549904451},{"date":"2022-09-23","current":-10.325363,"twenty":-20.642048,"median":-14.149216,"eighty":-11.72881,"marketCap":1473387928},{"date":"2022-09-30","current":-9.976196,"twenty":-20.374734,"median":-14.130616,"eighty":-11.651023,"marketCap":1423563216},{"date":"2022-10-07","current":-10.00945,"twenty":-20.25334,"median":-14.108764,"eighty":-11.612104,"marketCap":1428308426},{"date":"2022-10-14","current":-10.208974,"twenty":-20.041205,"median":-14.087145,"eighty":-11.550385,"marketCap":1456779691},{"date":"2022-10-21","current":-8.554588,"twenty":-19.925941,"median":-14.050563,"eighty":-11.479299,"marketCap":1220705457},{"date":"2022-10-28","current":-23.436216,"twenty":-20.25334,"median":-14.078409,"eighty":-11.519454,"marketCap":3344254210},{"date":"2022-11-04","current":-23.236229,"twenty":-21.228177,"median":-14.098831,"eighty":-11.528532,"marketCap":3315716985},{"date":"2022-11-11","current":-20.162877,"twenty":-21.051603,"median":-14.115937,"eighty":-11.5396,"marketCap":3508300306},{"date":"2022-11-18","current":-19.99039,"twenty":-20.642048,"median":-14.139963,"eighty":-11.550385,"marketCap":3478287831},{"date":"2022-11-25","current":-19.972233,"twenty":-20.383318,"median":-14.156214,"eighty":-11.558496,"marketCap":3475128624},{"date":"2022-12-02","current":-20.385295,"twenty":-20.609529,"median":-14.168551,"eighty":-11.575016,"marketCap":3547000602},{"date":"2022-12-09","current":-19.241431,"twenty":-20.426561,"median":-14.229892,"eighty":-11.597521,"marketCap":3347970508},{"date":"2022-12-16","current":-20.789279,"twenty":-20.651289,"median":-14.285748,"eighty":-11.6052,"marketCap":3617292976},{"date":"2022-12-23","current":-21.184185,"twenty":-20.782016,"median":-14.325872,"eighty":-11.6332,"marketCap":3686005747},{"date":"2022-12-30","current":-21.765195,"twenty":-20.907297,"median":-14.359697,"eighty":-11.634738,"marketCap":3787100398},{"date":"2023-01-06","current":-21.175106,"twenty":-21.113374,"median":-14.412372,"eighty":-11.64188,"marketCap":3684426143},{"date":"2023-01-13","current":-20.25366,"twenty":-20.996264,"median":-14.438221,"eighty":-11.644103,"marketCap":3524096345},{"date":"2023-01-20","current":-20.471539,"twenty":-20.932716,"median":-14.443856,"eighty":-11.654429,"marketCap":3562006839},{"date":"2023-01-27","current":-20.957227,"twenty":-21.021683,"median":-14.465518,"eighty":-11.668106,"marketCap":3646515649},{"date":"2023-02-03","current":-20.539626,"twenty":-20.962674,"median":-14.501863,"eighty":-11.693283,"marketCap":3573853869},{"date":"2023-02-10","current":-19.858755,"twenty":-20.927269,"median":-14.524498,"eighty":-11.719479,"marketCap":3455383575},{"date":"2023-02-17","current":-20.072094,"twenty":-20.907297,"median":-14.544872,"eighty":-11.729321,"marketCap":3492504267},{"date":"2023-02-24","current":-18.92823,"twenty":-20.885509,"median":-14.550984,"eighty":-11.733669,"marketCap":3293474173},{"date":"2023-03-03","current":-15.234288,"twenty":-20.849196,"median":-14.56482,"eighty":-11.744206,"marketCap":3404634746},{"date":"2023-03-10","current":-13.543976,"twenty":-20.829775,"median":-14.567395,"eighty":-11.755294,"marketCap":3026875555},{"date":"2023-03-17","current":-13.461609,"twenty":-20.800999,"median":-14.555428,"eighty":-11.765767,"marketCap":3008467797},{"date":"2023-03-24","current":-13.551139,"twenty":-20.774754,"median":-14.544872,"eighty":-11.782001,"marketCap":3028476229},{"date":"2023-03-31","current":-13.422217,"twenty":-20.713022,"median":-14.524498,"eighty":-11.796077,"marketCap":2999664087},{"date":"2023-04-06","current":-13.475934,"twenty":-20.653105,"median":-14.50704,"eighty":-11.802778,"marketCap":3011669147},{"date":"2023-04-14","current":-13.074843,"twenty":-20.651289,"median":-14.481561,"eighty":-11.805884,"marketCap":2922031372},{"date":"2023-04-21","current":-18.52965,"twenty":-20.644026,"median":-14.496144,"eighty":-11.808405,"marketCap":4141098868},{"date":"2023-04-28","current":-17.350338,"twenty":-20.637671,"median":-14.522192,"eighty":-11.817795,"marketCap":3877540192},{"date":"2023-05-05","current":-20.292744,"twenty":-20.608621,"median":-14.540806,"eighty":-11.820768,"marketCap":4535123986},{"date":"2023-05-12","current":-18.764855,"twenty":-20.608621,"median":-14.550984,"eighty":-11.830425,"marketCap":4596657665},{"date":"2023-05-19","current":-18.602803,"twenty":-20.594096,"median":-14.562246,"eighty":-11.831705,"marketCap":4556961197},{"date":"2023-05-25","current":-19.486465,"twenty":-20.588649,"median":-14.567395,"eighty":-11.837869,"marketCap":4773423882},{"date":"2023-06-02","current":-19.241641,"twenty":-20.566861,"median":-14.631091,"eighty":-11.848868,"marketCap":4713451537},{"date":"2023-06-09","current":-19.494115,"twenty":-20.535087,"median":-14.653628,"eighty":-11.860631,"marketCap":4775298018},{"date":"2023-06-16","current":-19.94551,"twenty":-20.51693,"median":-14.700243,"eighty":-11.866344,"marketCap":4885872030},{"date":"2023-06-23","current":-20.683807,"twenty":-20.530548,"median":-14.717194,"eighty":-11.866918,"marketCap":5066726135},{"date":"2023-06-30","current":-18.556898,"twenty":-20.521469,"median":-14.735995,"eighty":-11.867493,"marketCap":4545716382},{"date":"2023-07-07","current":-17.986917,"twenty":-20.50876,"median":-14.751068,"eighty":-11.869888,"marketCap":4406093265},{"date":"2023-07-14","current":-18.530121,"twenty":-20.492419,"median":-14.775826,"eighty":-11.883169,"marketCap":4539156907},{"date":"2023-07-21","current":-18.308249,"twenty":-20.476986,"median":-14.795999,"eighty":-11.893983,"marketCap":4484806969},{"date":"2023-07-28","current":-17.684713,"twenty":-20.449751,"median":-14.806507,"eighty":-11.917488,"marketCap":4332064901},{"date":"2023-08-04","current":-18.675485,"twenty":-20.429779,"median":-14.847747,"eighty":-11.938838,"marketCap":4574765487},{"date":"2023-08-11","current":-16.822179,"twenty":-20.409807,"median":-14.877903,"eighty":-11.965282,"marketCap":4453974775},{"date":"2023-08-18","current":-16.808001,"twenty":-20.39619,"median":-14.922726,"eighty":-11.987006,"marketCap":4450220898},{"date":"2023-08-25","current":-17.499178,"twenty":-20.39289,"median":-14.955882,"eighty":-12.021492,"marketCap":4633222391},{"date":"2023-09-01","current":-18.403025,"twenty":-20.387937,"median":-15.002599,"eighty":-12.049146,"marketCap":4872532034},{"date":"2023-09-08","current":-17.65868,"twenty":-20.370771,"median":-15.005716,"eighty":-12.05623,"marketCap":4675453504},{"date":"2023-09-15","current":-18.254156,"twenty":-20.34457,"median":-15.02393,"eighty":-12.07384,"marketCap":4833116328},{"date":"2023-09-22","current":-18.498726,"twenty":-20.336915,"median":-15.038325,"eighty":-12.101,"marketCap":4897870702},{"date":"2023-09-29","current":-17.793371,"twenty":-20.329918,"median":-15.05078,"eighty":-12.110314,"marketCap":4711115333},{"date":"2023-10-05","current":-16.981682,"twenty":-20.318417,"median":-15.056803,"eighty":-12.11436,"marketCap":4496205889},{"date":"2023-10-13","current":-16.074291,"twenty":-20.302625,"median":-15.087198,"eighty":-12.118714,"marketCap":4255957776},{"date":"2023-10-20","current":-16.481908,"twenty":-20.286743,"median":-15.148339,"eighty":-12.120899,"marketCap":4363881733},{"date":"2023-10-27","current":-17.109284,"twenty":-20.27474,"median":-15.149846,"eighty":-12.125268,"marketCap":4529990780},{"date":"2023-11-03","current":-16.942692,"twenty":-20.257291,"median":-15.15932,"eighty":-12.136983,"marketCap":4485882728},{"date":"2023-11-10","current":-15.261986,"twenty":-20.237319,"median":-15.186632,"eighty":-12.142826,"marketCap":4571193788},{"date":"2023-11-17","current":-15.913257,"twenty":-20.193743,"median":-15.226852,"eighty":-12.158302,"marketCap":4766259301},{"date":"2023-11-24","current":-15.671811,"twenty":-20.168324,"median":-15.249734,"eighty":-12.181733,"marketCap":4693942330},{"date":"2023-12-01","current":-16.446982,"twenty":-20.146536,"median":-15.273621,"eighty":-12.206635,"marketCap":4926117868},{"date":"2023-12-08","current":-18.038626,"twenty":-20.120209,"median":-15.310702,"eighty":-12.223784,"marketCap":5402838953},{"date":"2023-12-15","current":-19.249037,"twenty":-20.114441,"median":-15.345894,"eighty":-12.244421,"marketCap":5765375346},{"date":"2023-12-22","current":-18.858274,"twenty":-20.094761,"median":-15.397427,"eighty":-12.255986,"marketCap":5648336038},{"date":"2023-12-29","current":-20.113163,"twenty":-20.109873,"median":-15.413482,"eighty":-12.261481,"marketCap":6024193978},{"date":"2024-01-05","current":-20.440387,"twenty":-20.111189,"median":-15.447202,"eighty":-12.270831,"marketCap":6122202505},{"date":"2024-01-12","current":-19.061598,"twenty":-20.087206,"median":-15.502485,"eighty":-12.282097,"marketCap":5709234540},{"date":"2024-01-19","current":-19.32846,"twenty":-20.064832,"median":-15.526575,"eighty":-12.296687,"marketCap":5789163823},{"date":"2024-01-26","current":-20.141755,"twenty":-20.103564,"median":-15.604871,"eighty":-12.314783,"marketCap":6032757830},{"date":"2024-02-02","current":-26.753532,"twenty":-20.133863,"median":-15.653053,"eighty":-12.324561,"marketCap":8013084121},{"date":"2024-02-09","current":-26.696296,"twenty":-20.242766,"median":-15.671811,"eighty":-12.343291,"marketCap":7995941244},{"date":"2024-02-16","current":-27.009566,"twenty":-20.315086,"median":-15.741703,"eighty":-12.355101,"marketCap":8089770067},{"date":"2024-02-23","current":-26.599075,"twenty":-20.346777,"median":-15.756821,"eighty":-12.358131,"marketCap":7966821955},{"date":"2024-03-01","current":-19.791455,"twenty":-20.39058,"median":-15.767484,"eighty":-12.362433,"marketCap":7961429494},{"date":"2024-03-08","current":-19.338793,"twenty":-20.378033,"median":-15.787476,"eighty":-12.370073,"marketCap":7779338704},{"date":"2024-03-15","current":-18.670451,"twenty":-20.346777,"median":-15.797598,"eighty":-12.386838,"marketCap":7510487534},{"date":"2024-03-22","current":-18.228483,"twenty":-20.337432,"median":-15.827712,"eighty":-12.411509,"marketCap":7332698857},{"date":"2024-03-28","current":-18.460246,"twenty":-20.335365,"median":-15.836525,"eighty":-12.412327,"marketCap":7425929505},{"date":"2024-04-05","current":-17.075054,"twenty":-20.321747,"median":-15.83959,"eighty":-12.439419,"marketCap":6868713772},{"date":"2024-04-12","current":-17.471208,"twenty":-20.305095,"median":-15.881916,"eighty":-12.458883,"marketCap":7028073135},{"date":"2024-04-19","current":-16.389647,"twenty":-20.292744,"median":-15.911669,"eighty":-12.479472,"marketCap":6592997737},{"date":"2024-04-26","current":-16.238241,"twenty":-20.262738,"median":-15.930098,"eighty":-12.504692,"marketCap":6532092446},{"date":"2024-05-03","current":-17.452189,"twenty":-20.25366,"median":-15.962149,"eighty":-12.529434,"marketCap":7020422368},{"date":"2024-05-10","current":-16.330835,"twenty":-20.226425,"median":-15.977539,"eighty":-12.570574,"marketCap":7133700477},{"date":"2024-05-17","current":-18.791543,"twenty":-20.171955,"median":-16.02345,"eighty":-12.576745,"marketCap":8208596934},{"date":"2024-05-24","current":-17.252355,"twenty":-20.162877,"median":-16.044981,"eighty":-12.588189,"marketCap":7536242672},{"date":"2024-05-31","current":-17.486471,"twenty":-20.145979,"median":-16.069505,"eighty":-12.628691,"marketCap":7638510149},{"date":"2024-06-07","current":-18.059308,"twenty":-20.138199,"median":-16.100696,"eighty":-12.670073,"marketCap":7888739081},{"date":"2024-06-14","current":-18.432897,"twenty":-20.128139,"median":-16.153211,"eighty":-12.677887,"marketCap":8051931863},{"date":"2024-06-21","current":-18.121573,"twenty":-20.120209,"median":-16.193449,"eighty":-12.678628,"marketCap":7915937878},{"date":"2024-06-28","current":-19.618421,"twenty":-20.118394,"median":-16.224679,"eighty":-12.679369,"marketCap":8569796958},{"date":"2024-07-05","current":-18.993281,"twenty":-20.114892,"median":-16.24076,"eighty":-12.706999,"marketCap":8296721036},{"date":"2024-07-12","current":-20.412921,"twenty":-20.128139,"median":-16.30313,"eighty":-12.732244,"marketCap":8916853608},{"date":"2024-07-15","current":-20.520016,"twenty":-20.138199,"median":-16.303907,"eighty":-12.734601,"marketCap":8963635539},{"date":"2024-08-02","current":-19.57359,"twenty":-20.13731,"median":-16.304683,"eighty":-12.736958,"marketCap":8550213824},{"date":"2024-08-09","current":-16.530842,"twenty":-20.122025,"median":-16.304683,"eighty":-12.780687,"marketCap":8218936172},{"date":"2024-08-16","current":-17.608355,"twenty":-20.117486,"median":-16.330835,"eighty":-12.794946,"marketCap":8754662593},{"date":"2024-08-23","current":-17.54101,"twenty":-20.113163,"median":-16.355854,"eighty":-12.79665,"marketCap":8721179691},{"date":"2024-08-30","current":-17.796919,"twenty":-20.109873,"median":-16.382189,"eighty":-12.811343,"marketCap":8848414716},{"date":"2024-09-06","current":-25.164413,"twenty":-20.118394,"median":-16.416684,"eighty":-12.816444,"marketCap":12511444119},{"date":"2024-09-13","current":-28.394781,"twenty":-20.157687,"median":-16.444961,"eighty":-12.828575,"marketCap":14117544202},{"date":"2024-09-20","current":-29.138673,"twenty":-20.231872,"median":-16.459942,"eighty":-12.887955,"marketCap":14487398378},{"date":"2024-09-27","current":-27.725527,"twenty":-20.308425,"median":-16.491202,"eighty":-12.905778,"marketCap":13784799140},{"date":"2024-10-04","current":-27.635961,"twenty":-20.356246,"median":-16.541596,"eighty":-12.90971,"marketCap":13740268202},{"date":"2024-10-11","current":-27.765334,"twenty":-20.401715,"median":-16.572344,"eighty":-12.931873,"marketCap":13804590668},{"date":"2024-10-18","current":-28.762995,"twenty":-20.436258,"median":-16.616599,"eighty":-12.959362,"marketCap":14300615834},{"date":"2024-10-25","current":-27.944465,"twenty":-20.506036,"median":-16.648008,"eighty":-12.966906,"marketCap":13893652543},{"date":"2024-10-31","current":-26.399458,"twenty":-20.557783,"median":-16.667668,"eighty":-12.971839,"marketCap":13125493869},{"date":"2024-11-08","current":-25.214663,"twenty":-20.644026,"median":-16.733567,"eighty":-12.983254,"marketCap":12800173274},{"date":"2024-11-15","current":-22.754576,"twenty":-20.684289,"median":-16.791289,"eighty":-12.992224,"marketCap":11551315083},{"date":"2024-11-22","current":-21.701305,"twenty":-20.822787,"median":-16.813646,"eighty":-12.995724,"marketCap":11016624300},{"date":"2024-11-29","current":-23.162135,"twenty":-20.907297,"median":-16.822179,"eighty":-13.001558,"marketCap":11758211749},{"date":"2024-12-06","current":-22.10641,"twenty":-21.101995,"median":-16.843442,"eighty":-13.013917,"marketCap":11222274601},{"date":"2024-12-13","current":-21.573636,"twenty":-21.189632,"median":-16.875347,"eighty":-13.021971,"marketCap":10951813297},{"date":"2024-12-20","current":-21.166077,"twenty":-21.226278,"median":-16.929408,"eighty":-13.028697,"marketCap":10744916630},{"date":"2024-12-27","current":-21.060504,"twenty":-21.23055,"median":-16.99586,"eighty":-13.041117,"marketCap":10691322915},{"date":"2025-01-03","current":-20.451621,"twenty":-21.213463,"median":-17.04371,"eighty":-13.056938,"marketCap":10382224281},{"date":"2025-01-10","current":-19.901661,"twenty":-21.217735,"median":-17.069181,"eighty":-13.068397,"marketCap":10103038418},{"date":"2025-01-17","current":-21.563816,"twenty":-21.235455,"median":-17.105654,"eighty":-13.074127,"marketCap":10946827835},{"date":"2025-01-24","current":-22.090451,"twenty":-21.246134,"median":-17.110391,"eighty":-13.076047,"marketCap":11214173226},{"date":"2025-01-31","current":-22.575348,"twenty":-21.285242,"median":-17.144092,"eighty":-13.080045,"marketCap":11460330404},{"date":"2025-02-07","current":-21.854754,"twenty":-21.34285,"median":-17.212623,"eighty":-13.093733,"marketCap":11094522142},{"date":"2025-02-14","current":-20.5842,"twenty":-21.34285,"median":-17.248595,"eighty":-13.124157,"marketCap":10449528016},{"date":"2025-02-21","current":-20.247841,"twenty":-21.305793,"median":-17.268422,"eighty":-13.140798,"marketCap":10278775948},{"date":"2025-02-28","current":-20.59955,"twenty":-21.28584,"median":-17.296089,"eighty":-13.151072,"marketCap":9556687584},{"date":"2025-03-07","current":-20.763303,"twenty":-21.279088,"median":-17.346779,"eighty":-13.166601,"marketCap":9632656941},{"date":"2025-03-14","current":-20.266494,"twenty":-21.271161,"median":-17.38221,"eighty":-13.175744,"marketCap":9402173638},{"date":"2025-03-21","current":-20.666162,"twenty":-21.261605,"median":-17.434922,"eighty":-13.187616,"marketCap":9587590374},{"date":"2025-03-28","current":-19.642013,"twenty":-21.246879,"median":-17.48489,"eighty":-13.202598,"marketCap":9112459988},{"date":"2025-04-04","current":-8.481841,"twenty":-21.24317,"median":-17.461699,"eighty":-13.166601,"marketCap":3934955168},{"date":"2025-04-11","current":-7.782422,"twenty":-21.239771,"median":-17.384971,"eighty":-13.08988,"marketCap":3610475880},{"date":"2025-04-17","current":-8.082173,"twenty":-21.237354,"median":-17.363411,"eighty":-13.071978,"marketCap":3749538432},{"date":"2025-04-25","current":-9.578153,"twenty":-21.23055,"median":-17.338853,"eighty":-13.021611,"marketCap":4443563575},{"date":"2025-05-02","current":-9.79882,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"marketCap":4545937129},{"date":"2025-05-09","current":-7.961109,"twenty":-21.191447,"median":-17.258708,"eighty":-12.942759,"marketCap":4057180140},{"date":"2025-05-16","current":-7.821884,"twenty":-21.182369,"median":-17.225081,"eighty":-12.845455,"marketCap":3986227864},{"date":"2025-05-23","current":-8.593947,"twenty":-21.1733,"median":-17.165551,"eighty":-12.795287,"marketCap":4379690485},{"date":"2025-05-30","current":-8.302842,"twenty":-21.166077,"median":-17.133888,"eighty":-12.725172,"marketCap":4231335726},{"date":"2025-06-06","current":-8.809113,"twenty":-21.132441,"median":-17.109284,"eighty":-12.638816,"marketCap":4489344002},{"date":"2025-06-13","current":-8.723047,"twenty":-21.131367,"median":-17.105654,"eighty":-12.581323,"marketCap":4445482595},{"date":"2025-06-20","current":-8.454723,"twenty":-21.099418,"median":-17.04371,"eighty":-12.484516,"marketCap":4308738209},{"date":"2025-06-27","current":-8.323093,"twenty":-21.036935,"median":-16.897568,"eighty":-12.386838,"marketCap":4241656057},{"date":"2025-07-03","current":-8.416753,"twenty":-20.935584,"median":-16.843442,"eighty":-12.354346,"marketCap":4289387588},{"date":"2025-07-11","current":-9.173628,"twenty":-20.851011,"median":-16.810823,"eighty":-12.278742,"marketCap":4675109961},{"date":"2025-07-18","current":-9.459671,"twenty":-20.784084,"median":-16.720351,"eighty":-12.204334,"marketCap":4820884637},{"date":"2025-07-25","current":-9.173628,"twenty":-20.68477,"median":-16.635317,"eighty":-12.120899,"marketCap":4675109961},{"date":"2025-08-01","current":-8.593947,"twenty":-20.644026,"median":-16.553858,"eighty":-12.066419,"marketCap":4379690485},{"date":"2025-08-08","current":-7.116045,"twenty":-20.598459,"median":-16.480136,"eighty":-11.950749,"marketCap":3895998883},{"date":"2025-08-15","current":-7.452759,"twenty":-20.519399,"median":-16.437368,"eighty":-11.868483,"marketCap":4080348047},{"date":"2025-08-22","current":-7.566577,"twenty":-20.482433,"median":-16.366967,"eighty":-11.830425,"marketCap":4142663258},{"date":"2025-08-29","current":-7.296258,"twenty":-20.434352,"median":-16.309999,"eighty":-11.802778,"marketCap":3994664633},{"date":"2025-09-05","current":-7.623487,"twenty":-20.394374,"median":-16.243279,"eighty":-11.75253,"marketCap":4173820863},{"date":"2025-09-12","current":-7.839268,"twenty":-20.337432,"median":-16.175585,"eighty":-11.67955,"marketCap":4291960116},{"date":"2025-09-19","current":-7.727821,"twenty":-20.287494,"median":-16.074786,"eighty":-11.6332,"marketCap":4230943139},{"date":"2025-09-26","current":-7.621115,"twenty":-20.247841,"median":-16.038507,"eighty":-11.548594,"marketCap":4172522629},{"date":"2025-10-03","current":-9.515724,"twenty":-20.161579,"median":-15.967748,"eighty":-11.435788,"marketCap":5209811236},{"date":"2025-10-10","current":-9.956772,"twenty":-20.121117,"median":-15.919611,"eighty":-11.377135,"marketCap":5451282676},{"date":"2025-10-17","current":-10.336168,"twenty":-20.092195,"median":-15.848787,"eighty":-11.300594,"marketCap":5659000044},{"date":"2025-10-24","current":-9.864294,"twenty":-20.052985,"median":-15.830426,"eighty":-11.247666,"marketCap":5400651568},{"date":"2025-10-31","current":-10.61123,"twenty":-19.995479,"median":-15.795066,"eighty":-11.085574,"marketCap":5809595136},{"date":"2025-11-07","current":-8.308113,"twenty":-19.989732,"median":-15.765218,"eighty":-10.958851,"marketCap":5460100229},{"date":"2025-11-14","current":-9.072993,"twenty":-19.958021,"median":-15.674477,"eighty":-10.876553,"marketCap":5962780279},{"date":"2025-11-21","current":-9.495271,"twenty":-19.924444,"median":-15.629917,"eighty":-10.841973,"marketCap":6240301557},{"date":"2025-11-28","current":-9.881695,"twenty":-19.875402,"median":-15.51453,"eighty":-10.813365,"marketCap":6494259707},{"date":"2025-12-05","current":-9.176571,"twenty":-19.875402,"median":-15.428809,"eighty":-10.769092,"marketCap":6030851536},{"date":"2025-12-12","current":-8.881773,"twenty":-19.856979,"median":-15.337298,"eighty":-10.735643,"marketCap":5837110267},{"date":"2025-12-19","current":-8.706488,"twenty":-19.825078,"median":-15.267803,"eighty":-10.690375,"marketCap":5721912755},{"date":"2025-12-26","current":-9.491287,"twenty":-19.825078,"median":-15.226852,"eighty":-10.643534,"marketCap":6237683431},{"date":"2026-01-02","current":-9.190514,"twenty":-19.825078,"median":-15.171582,"eighty":-10.613914,"marketCap":6040014974},{"date":"2026-01-09","current":-9.02718,"twenty":-19.825078,"median":-15.141388,"eighty":-10.565682,"marketCap":5932671839},{"date":"2026-01-16","current":-9.56897,"twenty":-19.825078,"median":-15.056803,"eighty":-10.48168,"marketCap":6288736874},{"date":"2026-01-23","current":-10.722266,"twenty":-19.825078,"median":-15.039487,"eighty":-10.426172,"marketCap":7046684137},{"date":"2026-01-30","current":-10.521087,"twenty":-19.825078,"median":-15.022512,"eighty":-10.41063,"marketCap":6914468811},{"date":"2026-02-06","current":-11.775877,"twenty":-19.825078,"median":-15.002599,"eighty":-10.41063,"marketCap":7739118138},{"date":"2026-02-13","current":-12.00305,"twenty":-19.825078,"median":-14.938572,"eighty":-10.41063,"marketCap":7888416651},{"date":"2026-02-20","current":-12.520743,"twenty":-19.825078,"median":-14.868084,"eighty":-10.41063,"marketCap":8228644995},{"date":"2026-02-27","current":-11.263901,"twenty":-19.825078,"median":-14.836493,"eighty":-10.41063,"marketCap":8635221660},{"date":"2026-03-06","current":-10.93537,"twenty":-19.825078,"median":-14.789855,"eighty":-10.41063,"marketCap":8383361028},{"date":"2026-03-13","current":-10.552398,"twenty":-19.825078,"median":-14.736275,"eighty":-10.41063,"marketCap":8089763491},{"date":"2026-03-20","current":-10.133756,"twenty":-19.825078,"median":-14.633932,"eighty":-10.387838,"marketCap":7768821086},{"date":"2026-03-27","current":-10.2708,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":7873882950}],"updateTime":1774723896799},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCVX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605448385","title":"Vaxcyte: Expects to Report Topline Safety, Tolerability and Immunogenicity Data From Both Opus-2 and Opus-3 Phase 3 Studies in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2605448385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605448385?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:00","pubTimestamp":1769119215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nFWN3YN19Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","BK4139","PCVX","LU0053671581.USD"],"gpt_icon":0},{"id":"2605448431","title":"Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2605448431","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605448431?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:00","pubTimestamp":1769119200,"startTime":"0","endTime":"0","summary":"VAX-31 Adult Indication: Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza Vaccine (OPUS-2) and Expects to Initiate Phase 3 Study","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3224320/0/en/Vaxcyte-Advances-Adult-and-Infant-Programs-for-VAX-31-a-Potential-Best-in-Class-Next-Generation-Pneumococcal-Conjugate-Vaccine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU2237443465.HKD","LU0149725797.USD","BK4006","LU0971096721.USD","BK4023","LU2237443549.SGD","LU2237443382.USD","LU1169590202.USD","LU2746668461.USD","CMC","PD","IE00BZ1G4Q59.USD","LU0053671581.USD","LU1363072403.SGD","LU2237443978.SGD","LU2746668974.SGD","BK4139","LU0882574139.USD","IE00BKVL7J92.USD","IE00BFXG1179.USD","IE00BHPRN162.USD","LU2237443895.HKD","LU0267386448.USD","IE0009354923.USD","LU2237443622.USD","LU0170899867.USD","IE00B1BXHZ80.USD","PCVX"],"gpt_icon":0},{"id":"2601350073","title":"How Immunization Schedule Changes And Analyst Optimism Could Reframe Vaxcyte’s (PCVX) Vaccine Platform Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2601350073","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601350073?lang=en_us&edition=fundamental","pubTime":"2026-01-08 14:31","pubTimestamp":1767853882,"startTime":"0","endTime":"0","summary":"In early January 2026, a Mizuho analyst expressed optimism about Vaxcyte after recent changes to the U.S. immunization schedule, emphasizing the potential of its pneumococcal conjugate vaccine candidates VAX-31 and VAX-24.\nThis analyst commentary underscored how an expanded immunization framework could enhance the relevance of Vaxcyte’s multivalent vaccine platform, even as it remains a clinical-stage company with typical early-stage financial pressures.\nNext, we will examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/how-immunization-schedule-changes-and-analyst-optimism-could","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/how-immunization-schedule-changes-and-analyst-optimism-could","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2601085874","title":"Vaxcyte Inc : Needham Raises Target Price to $110 From $90","url":"https://stock-news.laohu8.com/highlight/detail?id=2601085874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601085874?lang=en_us&edition=fundamental","pubTime":"2026-01-07 19:01","pubTimestamp":1767783684,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2600093382","title":"Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600093382","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600093382?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:23","pubTimestamp":1767389017,"startTime":"0","endTime":"0","summary":"Harpreet S. Dhaliwal, Chief Technical Operations Officer of Vaxcyte Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL4fzwxT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","PCVX","LU0053671581.USD"],"gpt_icon":0},{"id":"2600087856","title":"Trade Alert: Senior Vice President of Finance Of Vaxcyte Elvia Cowan Has Sold Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2600087856","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600087856?lang=en_us&edition=fundamental","pubTime":"2026-01-01 18:50","pubTimestamp":1767264639,"startTime":"0","endTime":"0","summary":"Some Vaxcyte, Inc. ( NASDAQ:PCVX ) shareholders may be a little concerned to see that the Senior Vice President of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/trade-alert-senior-vice-president-of-finance-of-vaxcyte-elvi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/trade-alert-senior-vice-president-of-finance-of-vaxcyte-elvi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2593804784","title":"This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2593804784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593804784?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:19","pubTimestamp":1766409540,"startTime":"0","endTime":"0","summary":"Biotechnology company Vaxcyte hasn't yet justified investors hopes around its experimental pneumococcal disease vaccine. That could start to change in 2026, according to analysts at Mizuho Securities.Vaxcyte stock kept its place as one of Mizuho's top picks entering 2026, with the firm reiterating an Outperform rating and a $163 price target in a research note. Vaxcyte is advancing to phase 3 trials for its shot, VAX-31, in adults and phase 2 trials for infants. It could eventually be a leader in an $8 billion market, Mizuho argued.Mizuho's target implies a 250% jump from Friday's close and the stock has some key catalysts ahead. Vaxcyte is expected to initiate all adult VAX-31 phase 3 studies in 2026 and deliver a readout on the first of those trials by the end of the year. The company also should have results from infant phase 2 trials in the first half of 2027.Calling the vaccine \"broadly de-risked,\" Mizuho said it believes those results carry little downside for investors but plent","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","LU1430594728.SGD","LU1929549753.HKD","LU0130102774.USD","LU0208291251.USD","BK4592","LU0306806265.USD","LU0477156953.USD","SG9999001176.SGD","LU0130517989.USD","LU2112291526.USD","LU0320765646.SGD","SG9999014542.SGD","LU0058720904.USD","LU1934455194.USD","LU1983299246.USD","SG9999014559.SGD","SG9999001440.SGD","LU1571399168.USD","LU1989771016.USD","LU0203347892.USD","BK4585","BK4581","BK4568","LU1057294990.SGD","BK4550","BK4139","LU1093756168.USD","LU1291159041.SGD","LU2461242641.AUD","LU0265550946.USD","LU0234572021.USD","LU1066051225.USD","LU0306807586.USD","LU0211331839.USD","LU1116320737.USD","PCVX","SGXZ57979304.SGD","IE0002270589.USD","LU1941712264.USD","SG9999002232.USD","LU1066051811.HKD","IE00B19Z3581.USD","LU2125154935.USD","LU0861579265.USD","LU1116320901.HKD","IE00BLSP4452.SGD","SG9999003800.SGD","LU0203345920.USD","LU0106261372.USD","LU0238689110.USD","SG9999014575.USD","SG9999015341.SGD","IE00B2B36J28.USD","LU0225284248.USD","LU2361044865.SGD","LU2361044949.HKD","LU2324357040.USD","LU0980610538.SGD","LU1066053197.SGD","LU0985320562.USD","LU1934455277.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4599","LU1934455863.HKD","LU0965508806.USD","LU1061106388.HKD","LU0265550359.USD","LU0098860793.USD","LU0225771236.USD","LU0868494617.USD","LU0965509010.AUD","LU0965509283.SGD","LU1894683348.USD","LU0456855351.SGD","LU1035773651.USD","LU2023250504.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU2089984988.USD","LU0122379950.USD","LU0985481810.HKD","LU1941712348.USD","LU1037948897.HKD","LU2468319806.SGD","BK4588","LU0320765489.SGD","LU1989772840.SGD","LU1883839398.USD","IE0009355771.USD","LU0053671581.USD","LU0070302665.USD","LU1699723380.USD","LU1162221912.USD","BK4533","SG9999001176.USD","LU1037948541.HKD","LU0170899867.USD","IE00B1BXHZ80.USD","LU1201861249.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1069347547.HKD","LU2360032135.SGD","IE0002141913.USD","BK4007","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1974910355.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU2106854487.HKD","SG9999013999.USD","LU0965509101.SGD","LU0321505868.SGD","SG9999002224.SGD","LU2023250843.SGD","LU1989772923.USD","LU1066051498.USD","LU1917777945.USD","LU1894683264.USD","LU2361045086.USD","SG9999014567.USD","LU2125154778.USD","LU0006306889.USD","SG9999011175.SGD","LU1585245621.USD","IE00B19Z3B42.SGD","LU0266013472.USD","LU1093756325.SGD","BK4516","LU0321505439.SGD","BK4559","IE0009354923.USD","BK4534","SG9999015358.SGD"],"gpt_icon":0},{"id":"2592019721","title":"Vaxcyte Raises Executive Severance Multipliers in Amended Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2592019721","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592019721?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:11","pubTimestamp":1766178709,"startTime":"0","endTime":"0","summary":"Vaxcyte Inc. has amended its Executive Change in Control and Severance Agreements with key executives, including CEO Grant Pickering, President and CFO Andrew Guggenhime, COO Jim Wassil, and Chief Technical Operations Officer Harpreet Dhaliwal. Effective December 31, 2025, the base salary severance multiplier and COBRA severance multiplier in the event of a Qualifying Termination will increase to 1.5x for Mr. Pickering and 1.0x for Messrs. Guggenhime, Wassil, and Dhaliwal. In the event of a change in control  Qualifying Termination, the base salary severance multiplier, target annual bonus severance multiplier, and COBRA severance multiplier will increase to 2.0x for Mr. Pickering and 1.5x for Messrs. Guggenhime, Wassil, and Dhaliwal. These adjustments bring the severance components more in line with peer group levels.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLlb1SF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"2590322194","title":"Vaxcyte (PCVX): Reassessing Valuation After OPUS Phase 3 Trial Start for Next-Generation Pneumococcal Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322194","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322194?lang=en_us&edition=fundamental","pubTime":"2025-12-10 01:28","pubTimestamp":1765301329,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) just hit a key milestone by dosing the first participants in its OPUS Phase 3 trial of VAX-31, a head-to-head study against current adult pneumococcal vaccines that supports its future approval plans.\nSee our latest analysis for Vaxcyte.\nThat backdrop helps explain why, even with a sharp year to date share price return of minus 44.56 percent and a one year total shareholder return of minus 49.84 percent, the recent three month share price rebound of 41.14 percent suggests...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-reassessing-valuation-after-opus-phase-3-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-reassessing-valuation-after-opus-phase-3-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","OPUS","BK4139","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"2589358800","title":"BRIEF-Vaxcyte Says Topline Results From OPUS Trial Expected In Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358800?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:35","pubTimestamp":1765197333,"startTime":"0","endTime":"0","summary":"BRIEF-Vaxcyte Says Topline Results From OPUS Trial Expected In Q4 2026Dec 8 (Reuters) - Vaxcyte Inc PCVX.O:VAXCYTE DOSES FIRST PARTICIPANTS IN THE OPUS PHASE 3, NONINFERIORITY TRIAL EVALUATING VAX-31 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUABSGKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2589261337","title":"Vaxcyte Begins Phase 3 Trial of VAX-31 Pneumococcal Vaccine in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2589261337","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589261337?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195227,"startTime":"0","endTime":"0","summary":"Vaxcyte Inc. has announced the initiation of the OPUS Phase 3 pivotal, noninferiority clinical trial evaluating VAX-31 for the prevention of invasive pneumococcal disease  and pneumonia in adults. The trial, which aims to enroll approximately 4,000 participants, was designed in consultation with the U.S. Food and Drug Administration and will compare VAX-31 to current standard-of-care vaccines Capvaxive  and Prevnar 20 . Topline safety, tolerability, and immunogenicity results from the OPUS trial are expected in the fourth quarter of 2026. Additional Phase 3 studies are planned to begin in 2026, with results anticipated in 2027. No results from these studies have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL5Csw2v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","BK4585","BK4139","SG9999014013.SGD","IE0009354923.USD","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4588","BK4112","IE00BGHQF748.EUR","LU0053671581.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","PCVX","SG9999014021.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2589337753","title":"Vaxcyte Doses First Participants in the Opus Phase 3, Noninferiority Trial Evaluating Vax-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337753?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUABSGKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PCVX","IE0009354923.USD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2589337711","title":"Vaxcyte Inc - Topline Results From Opus Trial Expected in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337711?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUABSGKG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2588772529","title":"Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men","url":"https://stock-news.laohu8.com/highlight/detail?id=2588772529","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588772529?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:35","pubTimestamp":1764610500,"startTime":"0","endTime":"0","summary":"Vinay Prasad, a top regulator at the FDA, did not detail the data in the internal memo that led to the conclusion. Pfizer and BioNTech developed the COVID-19 vaccine Comirnaty.Shares of Moderna and BioNTech were down on Monday morning, likely in response to a FDA official's memo outlining a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children.Concern about that link, particularly relating to teenage boys and young men, has been a key argument against administering mRNA-based COVID vaccines in children.Vinay Prasad, the head of the Food and Drug Administration's Center for Biologics Evaluation and Research, reportedly issued a memo to staff last week that said the regulator plans to acknowledge that 10 children died after getting the vaccine. . The FDA has not publicly shared the internal research cited in the memo, although Prasad said it comes from the Vaccine Adverse Event Reporting System, which gathers reports of adverse events from the public, healthcare profe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0058720904.USD","LU0225284248.USD","IE0002270589.USD","LU1057294990.SGD","LU1894683348.USD","BK4551","BK4532","SG9999011175.SGD","LU0306806265.USD","LINK.USD.HKCC","BK4581","IE00B19Z3B42.SGD","LU0053671581.USD","LU0321505439.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999013999.USD","BK4585","LU0225771236.USD","SG9999003800.SGD","LU1066053197.SGD","LU1894683264.USD","VXRT","LU1023059063.AUD","SG9999001176.USD","LU0170899867.USD","SGXZ57979304.SGD","MRNA","LU0122379950.USD","LU0985481810.HKD","LU1066051498.USD","IE00BLSP4239.USD","BK4599","BK4535","SG9999001176.SGD","BK4592","LU1883839398.USD","PCVX","IE00BLSP4452.SGD","LU0306807586.USD","BNTX","DVAX","BK4139","BK4568","IE000M9KFDE8.USD","LU0456855351.SGD","LU0234572021.USD","BK4534"],"gpt_icon":1},{"id":"1187950486","title":"Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=1187950486","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187950486?lang=en_us&edition=fundamental","pubTime":"2025-12-01 23:25","pubTimestamp":1764602721,"startTime":"0","endTime":"0","summary":"Moderna Inc. fell Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.Vinay Prasad, a top FDA official, blamed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"de4e5ce05b2acd5962228944615f4d01","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","PCVX","HIMS","NVAX","BNTX","MRK","MRNA","VIR","BIIB","REGN","AMGN"],"gpt_icon":0},{"id":"2588720367","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720367","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588720367?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:02","pubTimestamp":1764594138,"startTime":"0","endTime":"0","summary":"Aditxt (ADTX) stock was down 15% pre-bell Monday, paring Friday's increase.CEA Industries (BNC) shares were 12% lower, shaving gains from the previous session.Jiayin Group (JFIN) stock was down 11% after Friday's 1% loss.Vaxcyte (PCVX) shares were 11% lower following a muted session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADTX","IE0009354923.USD","BK4086","JFIN","LU0053671581.USD","BK4139","PCVX","BK4166","BNC"],"gpt_icon":0},{"id":"2588727883","title":"S&P 500 Futures Fall In Premarket Trading; Vaxcyte, Cipher Mining Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727883","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588727883?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:31","pubTimestamp":1764592260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Barrick Mining Corp.  was up 4.5% in pre-market trading, and Teck Resources Ltd. Cl B  was up 3.5%.Coeur Mining Inc. , Primo Brands Corp. , and Hecla Mining Co.  were all posting gains of at least 3%. In early trading, Vaxcyte Inc.  and Cipher Mining Inc.  had posted declines, falling 10.8% and 7.4%, respectively.Meanwhile S&P 500 futures were down 0.69%, with futures for the Dow Jones Industrial Average falling 0.45%. The Cboe Volatility Index futures were down 2.93%.In commodities news, Brent crude oil futures were up 1.15%, while gold futures were up 0.81%. Bitcoin fell 5.86% to $85,986.In the previous regular trading session, the S&P 500 and the Dow were up 0.54% and 0.61%, respectively. Stocks in Asia were mixed overnight, with Japan's NIKKEI 225 Index down 1.89% and China's Shanghai Composite Index up 0.65%.U.S. stock markets open for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4210","LU0498741114.HKD","BK4023","HL","BK4161","BK4139","SDS","BK4570","LU1223082519.USD","LU0345781412.USD","CDE","LU1223082196.USD","BK4581","IVV","BK4550","LU0075056555.USD","LU0496367417.USD","LU0345780281.USD","BK4017","LU0300736492.USD",".SPX","BK4588","BK4585","OEF","OEX","PRMB","TECK","BK4595","LU0345780950.USD","SH","LU0788109121.HKD","BK4534","UPRO","CIFR","LU0330918003.SGD","SSO","LU0345780521.USD","B","LU0630314457.HKD","MESmain","LU0053671581.USD","LU0368265764.SGD","PCVX","BK4600","ESmain","SPY","VOO","LU1023059493.AUD","SPXU","BK4168"],"gpt_icon":1},{"id":"2584463918","title":"U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2584463918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584463918?lang=en_us&edition=fundamental","pubTime":"2025-11-19 15:17","pubTimestamp":1763536636,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron TechnologyNov 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4N3WV0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WCC","COTY","LU0820561818.USD","BK1609","PRAX","VTVT","SG9999015358.SGD","DKS","LU0127658192.USD","LU0353189763.USD","LU0266013472.USD","IPAR","INCY","ARWR","KNTK","OLMA","DASH","PCVX","ENR","ZION","LU2498475776.HKD","LU2756315664.SGD","MBI","UHS","LU0289739699.SGD","MU","LU2039709279.SGD","ZYME","RAPP","RARE","89888","TERN","LGIH","LU1585245621.USD","SION","CRWD","BK4549","NUVB","BK4548","SG9999014542.SGD","LU0079474960.USD","FCX","AMGN","LU2065170008.USD","BRBR","HD"],"gpt_icon":1},{"id":"2584991650","title":"Vaxcyte Inc : Leerink Partners Raises Target Price to $77 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2584991650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584991650?lang=en_us&edition=fundamental","pubTime":"2025-11-19 11:56","pubTimestamp":1763524567,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nFWN3WU13B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2584864917","title":"Is Vaxcyte’s (PCVX) Aggressive R&D Spend Still Justified Amid Widening Losses?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584864917","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584864917?lang=en_us&edition=fundamental","pubTime":"2025-11-17 15:17","pubTimestamp":1763363850,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. recently reported its third quarter and nine-month 2025 earnings, revealing a net loss of US$212.83 million for the quarter and US$520.12 million for the year to date, both considerably higher than the previous year’s losses.\nThe increased loss per share may draw attention to the company’s spending pace as it continues to invest in pipeline and development activities.\nWe'll examine how Vaxcyte's wider quarterly loss shapes investor perspectives on its path to future...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/is-vaxcytes-pcvx-aggressive-rd-spend-still-justified-amid-wi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/is-vaxcytes-pcvx-aggressive-rd-spend-still-justified-amid-wi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":95,"code":"91000000","status":"200"}]}}